key: cord-0694006-egt9v7f7
authors: nan
title: Critical Care Canada Forum 2020 Abstracts
date: 2021-01-09
journal: Can J Anaesth
DOI: 10.1007/s12630-020-01870-7
sha: c66c01a29ed9427d2ad2e07a30554443d94eac3a
doc_id: 694006
cord_uid: egt9v7f7

nan

Early 2020, the Novel Coronavirus (COVID-19) overwhelmed healthcare systems. Inadequate critical care resources, including supplies and ventilators to support the volume of anticipated patients suggested we needed to prepare immediately. Objectives: The decision to prepare was three-fold: evaluate current state preparing to expand space and care delivery by 58% immediately; maximize critical care, ventilator capacity and resources to create 106 beds; develop a monitoring system for capacity, equipment and supplies. Methods: Over 8 weeks, administrative leadership, professional practice, practice leads; infection prevention & control (IPAC) and supply chain specialists held daily video meetings to coordinate immediate needs. A Critical Care dashboard was created, providing a twice daily snapshot of beds available, ventilators, dialysis availability, critical drugs and supplies; and the number of COVID-19 positive patients. A new chronic ventilation unit (CVU), on a respiratory ward was created with support of Registered Respiratory Therapists (RRT). Ward nurses were trained over a three-week period on ventilation, using a multi-modal approach. RRTs working as pulmonary function technologists were re-deployed and trained to manage chronic ventilators, daily tracheostomy care and maintenance of critical care respiratory equipment. Logistically, the Post Anaesthetic Care Unit (PACU) space was outfitted with an additional Omnicell for medication management, and equipment and supplies to support an ICU patient population. Operating rooms (OR) remained operational for emergent cases, and patients recovered in ORs to prevent contamination from satellite ICU patients. Nurses from PACU, Same Day Surgery (SDS), and ORs received critical care education and utilized a "team" nursing model led by an ICU lead. Anesthesia assistants (AA) were re-deployed to work alongside RRTs. RRTs were trained on Anaesthetic Gas Machines (AGM) by AAs. Critical supplies were monitored with a threshold for re-ordering and twice weekly reporting. Simulation exercises on donning and doffing of personal protective equipment, protected intubations and extubations, 7 code blue and proning were ongoing. Results: Mobilization of resources to support 106 Critical Care beds was completed. Two phases planned, an increase to 60 beds, with a plan to add 46 more. Capacity was created by operationalizing a CVU, a satellite ICU, and 4 additional monitored nonventilated beds on a Cardiology unit. To mitigate the risk, critically ill COVID19 suspect or positive patients remained in the main ICU. Of the 48 critically ill COVID-19 cases, 58% were from the ward, 42% were from the Emergency Department. Seventy six to ninety percent of all ICU patients required ventilation, maintaining a high ventilator and supply demand. Conclusions: Capacity was planned for 106 patients, 60 beds were utilized. Patients requiring ventilation remained high increasing a need for respiratory therapists by almost 20%. Additionally, ICU, PACU, OR and SDS nurses worked collaboratively to provide care to critically ill patients in a satellite ICU. Adaptability, resilience and enhancement of newly formed inter-professional and inter-unit teams were unexpected outcomes. Partnerships, efficiencies, and processes in safety and IPAC measures were strengthened maximizing resources. Humber River Hospital is well positioned to maintain a readiness to respond to expected waves in the future. others suggest equivocal or improved outcomes. [5] [6] [7] Nova Scotia (NS) is an ideal setting to investigate the effect of inter-facility transfer on ICU as it has a single tertiary care adult ICU that receives regular transfers from 11 regional and community ICUs. Objective: The objective of this study is to estimate differences in case-mix adjusted hospital mortality between adult ICU patients in NS that are transferred during their ICU visit compared to those that are not transferred. Methods: All visits to 12 adult medical-surgical ICUs in NS between April 1, 2018 and March 31, 2020 were analyzed. For each visit, data on patient demographics, transfer status, APACHE IV score, ventilation, delirium, mortality, and length of stay was obtained from the NS Provincial ICU database. The NS Provincial ICU database has prospectively captured data since April 1, 2018 for all patients admitted to one of the 12 adult ICUs in the province. A generalized linear mixed effects model was used to estimate differences in the case-mix adjusted hospital mortality between patients that are transferred between ICUs during their ICU visit and those that are not transferred. A generalized linear mixed effects model was chosen as it controls for differences in case-mix via fixed effects while also controlling, via random effects, for random variability present in ICU care at different centers. Fixed effects used to control for case-mix included Acute physiologic and chronic health evaluation (APACHE) IV predicted mortality, APACHE IV admit diagnosis category, location prior to ICU admission, pre-ICU length of stay (hrs), ventilation in the first 24 hours, age, gender, and transfer during ICU stay. Odds ratios (OR) were calculated to determine differences in hospital mortality between patients that were transferred and those that were not. Results: A total of 10,028 ICU visits were recorded from April 1, 2018 to March 31, 2020. 395 ICU visits (3.94% of all ICU visits) involved transfers between ICUs. In patients that were transferred during their ICU stay, hospital mortality was 25.3% (100 of 395), APACHE IV predicted hospital mortality was 28.4%, and standardized mortality ratio (SMR) was of 0.89. In patients that were not transferred during their ICU stay, hospital mortality was 18.2% (1758 of 9633), APACHE IV predicted hospital mortality was 16.05%, and SMR was of 1.13. Generalized linear mixed effects modelling showed that ICU stay was associated with a 0.2 percent decrease in the relative odds of hospital mortality (OR = 0.998) at fixed levels of the remaining covariates, but this association was not statistically significant at level 0.05 (p = 0.99). Conclusions: Our analysis showed that the transfer of critically ill patients between ICUs in NS does not result in lower hospital mortality after correction for differences in case-mix. Further analysis is required to determine if transfers result in mortality benefit in certain sub-groups of ICU patients. Greater scrutiny may be needed to determine which ICU patients warrant transfer between ICUs in order to balance the risks of transfer with any potential benefits. 

Nostedt, Sarah 1 ; Joffe, Ari 1 1 Pediatric Critical Care Medicine, Stollery Children's Hospital, Edmonton, Alberta, Canada

Introduction: Misinterpretation of null-hypothesis statistical testing (NHST) prevents recognition of high false positive rates (FPR), and may account for poor reproducibility of studies. Objectives: We aimed to determine the implications of reported p-values and statistically significant findings in pediatric critical care randomized controlled trials (RCT's).

The EPICC database reports abstracts of all 444 published pediatric critical care RCT's from 1980-2019. We searched EPICC separately for 'mortality' (n=135) and 'more than 1 center' (n=80) studies. We excluded studies with 1 or no deaths, not reporting on deaths, having pilot feasibility or short-term physiologic outcomes only, or non-obtainable publication (only n=2). This generated 120 RCT's with a mortality outcome. Reverse Bayesian implications from the publications were obtained, including FPR (defined as a statistically significant finding that is due to chance alone).

Results: Of 120 studies, 73 (61%) were single center, sample-size/group was median 40 [ IQR 22, 80] , patients often had sepsis (22%) or were ventilated (36%), and mortality was the primary outcome in 16%. Reported p-values were ≤0.005 in 1.7%, 0.0051-0.05 in 8.3%, and 0.051-0. 10 and iv) probability that a replication study would find a p ≤0.05 was 60.9% [IQR 57.9, 73.9]. By calculating post-hoc power for medium effect sizes, and assuming PrP(H1) 50%, in the field of pediatric critical care, the PPV and NPV of studies using α≤0.05 can be expected to be 64.3% [IQR 28.6, 86.5] and 51.1% [IQR 49.2, 58.3] respectively. Assuming a more realistic PrP(H1) 10%, the PPV and NPV can be expected to be 28.6% [IQR 8.2, 55 .0] and 91.2% [IQR 89.9, 95 .0]. Conclusions: Pediatric critical care RCT's with statistically significant mortality outcomes have a high FPR, much higher than the misinterpretation that a p-value ≤0.05 implies a FPR of 5%. In this field, as in many others, most published findings can be expected to be false. We agree with recent recommendations to design RCT's with α=0.005, and to report the FPR of study findings assuming Pr P (H1) 10%.

Introduction: Between 75-80% of patients with sepsis arrive through the emergency department (ED). Early recognition and diagnosis are important to alter patient prognosis. We have shown that coagulation markers are important for prognosis in the intensive care unit. Inflammation and coagulation are linked in the innate immune response. The role of coagulation markers to aid in sepsis diagnosis in the ED has had limited investigation.

The primary objective is to identify the changes in the coagulation biomarkers occurring in septic patients presenting to the ED. The secondary outcome is to identify a panel of biomarkers (including inflammatory and coagulation markers) with the routinely used laboratory tests and clinical scores of abnormal vital signs and organ dysfunction to aid in sepsis diagnosis. Methods: SEPSIS-ED is an observational cohort study with a planned recruitment of 250 adult patients with the suspicion of sepsis from two EDs in Hamilton, Ontario. Samples were collected at two points: on their initial presentation to the ED (Timepoint 1) and 4 hrs after the initial sample collection (Timepoint 2). Cell-free DNA (cfDNA) levels was determined from plasma samples using a silica-membrane based DNA purification method and UV spectrophotometry. Procalcitonin, protein C (PC) and a Disintegrin and Metalloprotease with Thrombospondin type 1 motif, member 13 (ADAMTS13; an enzyme that cleaves Von Willebrand Factor) levels were measured using enzyme-linked immunosorbent assays. These markers will be compared with healthy controls (HC). Each case with suspected sepsis will be adjudicated using the Sepsis-3 definition to determine the septic or non-septic status. 1 Data is reported as mean ± standard deviation or median (Interquartile range) depending on whether normally distributed. Results: We report preliminary unadjudicated data on 174 patients presenting with the suspicion of sepsis to the ED, with a mean age of 69.2 ± 17.6 years, 51.7% of males, and mortality of 7.4% at 28 days. 71.8% of the patients had a SOFA score of more than 2. The leukocyte count was (14.5 ± 9.2 ×10 9 /L) elevated compared to hospital standard, while platelet count (238.1 ± 117.4 ×10 9 /L) was within the normal range. cfDNA and PC levels at both time points were not significantly different from the healthy controls. Procalcitonin levels were significantly higher in our cohort at both time points compared to the healthy controls (HC: 84.81 (44.06) pg/ml, T1: 146.2 (460.27) pg/ml, T2: 176.1 (523.08) pg/ml, p<0.0005). We also observed that ADAMTS13 levels were significantly lower than healthy controls and declined further 4 hours after the initial presentation to the ED (HC: 897 (456.7) ng/ml, T1: 417.3 (340.3) ng/ml, T2: 363 (281.7) ng/ml, p<0.0001).The multivariance receiver operating characteristic (ROC) curve analyses with the combination of biomarkers, vitals and laboratory parameters were performed. Amongst the various panels analyzed (table 1) , a six-marker panel (including cfDNA, PC, procalcitonin, ADAMTS13, respiratory rate and heart rate) had the highest ROC area under the curve (T1: 0.757 and T2: 0.743). Conclusion: Our preliminary data suggests that patients presenting to the ED with suspicion of sepsis have an associated coagulopathy as demonstrated primarily by a decrease in ADAMTS13, a marker linked to the initial inflammatory response. These results provide a rationale for exploring the impact of coagulation markers to facilitate

Al-Ani, Tammar 1 ; Tatarkowska, Nina 2 1 Anaesthesia and Intensive Care, NHS Greater Glasgow and Clyde, Glasgow, United Kingdom 2 Anaesthesia and Intensive Care, NHS Lanarkshire, East Kilbride, United Kingdom Introduction: The National Health Service (NHS) in the United Kingdom has published patient safety alert '' Risk of inadvertently cutting in-line (or closed) suction catheters'' reporting nine incidents describing retained suction catheter tips in neonates and adults airway between January 2012 and August 2014 that appear to have resulted in moderate harm. Local investigations have identified the following: (1) In closed suction systems for neonates, the suction catheter is not easily visible if left inside the ET tube;

(2) It was not always documented when and by whom the ET tube was cut; (3) Some patients were suctioned regularly and staff failed to fully withdraw the catheter following suction. Objective: We report a case of inadvertently cutting closed loop suction catheter and implement strategies in order to prevent this human error. Method: A 46-year-old male was intubated with an uncut Endotracheal Tube (ET) and ventilated in the Intensive Care Unit (ITU) due to respiratory failure as a result of community-acquired pneumonia. The ET needed to be cut while in situ in order to reduce dead space and facilitate lung suctioning; this was performed by senior ITU doctor and documented as straightforward procedure. Following this procedure, the patient oxygen requirement started going up with the ventilator started alarming air trapping and increasing end tidal carbon dioxide. A chest x-ray was performed and reported by the radiologist as left lower lobe volume loss and pleural effusion with no intrapulmonary abnormality demonstrated on the right side, multiple bilateral rib fractures noted. Results: The tip of closed loop suction catheter was left inside the ET and was accidently cut and fell into patient airway. This was only noticed twenty-four hours after when the catheter tip was identified lying inside the bronchus intermedius and occluding the right middle lobe bronchus and subsequently removed by bronchoscopy (image1). Conclusion: Cutting of ET while in situ is an invasive procedure that could result in serious complications; this could be related to loss of airway or accidental cutting of closed loop suction catheter which can result in airway obstruction, infection and the need of undertaking invasive procedure to retrieve the foreign object. Introducing a step-by-step checklist for ET cutting while in situ (Image 2) could help to standardize practice and eliminate complications.

Image 2 -Invasive Procedure Checklist: In situ endotracheal tube (ETT) cutting Introduction: The need for donated organs vastly outweighs the number available for transplant in Canada. The disparity among availability of organs and identified need highlights that exploring factors affecting donation and transplantation should be a research priority. To explore these issues, Canadian Blood Service (CBS), a national not-for -profit charitable organization that manages organ and tissue donation and transplantation in Canada, commissioned Ipsos Reid to conduct a series of Canadian public surveys exploring awareness, knowledge, behaviours, and attitudes to organ and tissue donation. Thus, the purpose of this study was to explore and analyze this data in order to identify factors predictive of the intent to consent to organ donation, factors predictive of overriding another individual's pre-declared intent to donate their organs, and factors predictive of support for an opt-out consent model to organ donation legislation in Canada. Changes over time related to these factors were also explored. Methods: We conducted a secondary analysis of four years of Canadian survey data, using univariate and multivariate regression analyses of various demographic variables against respondents' intent to donate their organs upon their death, support for an optout model of consent for organ donation, and willingness to override another's decision to donate their organs upon their death. Results: Between 44%-46% of respondents remain undecided about their intent to donate organs for all years of study. Those with more knowledge of organ donation and who had higher approval ratings of organ donation were also more likely to declare their intent to donate. Intent to donate was found to be predictive of support for the optout model of consent for organ donation. And individuals that did not support organ donation or who were not intending to donate were more willing to override another's decision to donate. The year of study was not significantly associated with any of the outcomes of interest. Conclusions: This is the first detailed analysis of previously unpublished Canadian Blood Services survey data. Our results suggest there is a need to explore qualitative and social factors that influence the personal decision to consent to organ donation as well as how these factors affect attitudes to opt-out consent and overriding another's decision to donate. Greater understanding in these areas will assist in creating initiatives targeted at potential gaps in education or service that would also affect the success of implementing legislative changes in other jurisdictions. 13 ; Opgenorth, Dawn Objectives: To examine outcomes associated with the implementation of a prospective antimicrobial stewardship program (ASP), procalcitonin (PCT) testing, and rapid blood culture identification (BCID) in adult intensive care unit (ICU) patients with suspected or confirmed sepsis. Methods: We conducted a prospective, adaptive, time series evaluation of ASP using prospective audit and feedback, PCT and BCID in all adult ICU patients with suspected or confirmed sepsis (Sepsis-3 definitions) in two large academic mixed medical/surgical ICUs in Alberta in 2018. The study included 12-week baseline data (Phase 1) and implementation (Phase 2) phases. During implementation, ASP audits were conducted on admission and in follow-up 2-5 days post-admission. PCT was measured daily to a maximum of 7 days or until ICU discharge and BCID was performed on all positive blood cultures. The primary outcome was in-hospital mortality. Secondary outcomes included initial antimicrobial concordance with clinical practice guidelines, number and acceptance of ASP interventions, antimicrobial and health resource utilization, ICU and hospital lengths of stay and re-admissions, and costs and quality-adjusted life years (QALYs). Segmented logistic and linear regression analyses were performed to estimate associations. Results: A total of 727 patients were included, 342 in Phase 1 and 385 in Phase 2. Patients were similar in phase 1 vs. 2, with mean (±SD) ages 59 (±15) and 57 (±15), 59% and 56% male sex, and APACHE II scores 24 (±7) and 24 (±9), respectively. There was no difference in hospital mortality between phases (25 vs 26%; p=0.75]. The ASP team conducted 1023 assessments (692 initial; 331 follow-up) and reviewed 1247 prescriptions. 808/1247 (65%) of prescriptions were judged as appropriate while 122/1247 (10%) were considered not indicated by the ASP team. Empiric antimicrobials were guideline concordant in 861/998 (86.3%) of prescriptions. Full compliance with ASP recommendations was high (93%). Substantial changes in antimicrobial utilization (DDD/100 patient-days) included a 12% increase for thirdgeneration cephalosporins, 11% increase for vancomycin utilization and a 19% reduction in piperacillin/tazobactam utilization. PCT was measured at least once in 383 (99.5%) intervention patients (median 5.0 tests per patient). 277 (15%) PCT values were <0.25 ng/mL (stopping rule) while 1188 (66%) were >1 ng/mL (continuation rule). There were 44 positive blood cultures; most common isolates identified were Staphylococcus aureus and Escherichia coli. There were no differences in change in daily SOFA score, incidence of delirium, or use and duration of mechanical ventilation, vasopressors or renal replacement therapy. Mean ICU stay was shorter in the intervention phase (-2.15 days; 95%CI -3.85, -0.45, p=0.013); however, there were no differences in hospital stay or ICU or hospital readmission rates. Costs were decreased (-$12,834 per patient) and QALYs were increased (0.16 vs 0.13) in the intervention phase compared with baseline. Conclusions: ASP, PCT and BCID testing were effectively implemented and can aid in guiding antimicrobial prescriptions in adult critically ill patients with sepsis. Empiric antimicrobial prescriptions were highly guideline-concordant and ASP was well accepted. There were no differences in mortality or health resource utilization postimplementation but shorter ICU stays and and associated cost-savings were observed.

Grant Acknowledgement: Funding provided by Alberta Innovates, Alberta Health Services and bioMèrieux. Alberta Innovates managed and distributed the funds to the study team.

Reynen, Emily Objectives: Our primary objective is to retrospectively characterize the degree of adherence between care received and CPG for patients admitted to the ICU with TBI. Our secondary objective is to evaluate mortality and functional outcomes. Methods: This study is a retrospective analysis of all patients aged 18 years or older admitted to our level 3 ICU with a TBI between January 1, 2012 and December 31, 2017. Ethics approval was granted by the Queen's University Health Sciences & Affiliated Teaching Hospitals Research Ethics Board (HSREB). Eligible participants were identified through the patient discharge database using ICD 10 codes. Data was retrieved manually from patients' electronic charts and entered into a de-identified standardized data extraction excel spreadsheet. Descriptive statistics including median and interquartile ranges (IQR) were used to analyze the data. Outcomes of interest include patient demographic data, interventions used in case management, morbidity and mortality. Missing data was quantified as a proportion of the total data available. Results: A total of 326 patients were identified, of these, 311 were eligible for inclusion. The most common reason for exclusion from the study was patients who did not experience a TBI. Key baseline characteristics are reported in Table 1 . A CT head was completed in 307 patients (99%), of which 283 (92%) had an abnormal finding. The median Marshall score was 3 (IQR: 2 to 5). Neurosurgical interventions were performed in 127 patients (41%), the most common being a crainiotomy (n=44). Interventions to lower ICP were used in 117 patients and 48 patients had an ICP monitor placed. Details of ICP lowering therapy are outlined in table 2. A total of 46 patients experienced a seizure prior to arrival at KHSC. Of the 262 patients who did not experience a seizure prior to presenting to hospital, 72 (27%) received seizure prophylaxis. Anti-seizure medications received are described in figure  1 . Median duration of seizure prophylaxis was 7 days (IQR: 7 to 14 days). Despite prophylaxis, 20 patients experienced a seizure, of which 7 were diagnosed clinically and 13 on EEG. The median mRS at time of discharge or transfer was 4 (IQR: 3 to 6). The median length of ICU stay was 6 days (IQR: 2 to 11) and total hospital stay was 11 days (IQR: 3 to 26). When available, the most common discharge destination was a rehabilitation facility (25%) followed by home (with or without supports) in 21%. Goals of care were documented on the official KHSC form in 13 (4%) of cases. A total of 102 (33%) of patients died before hospital discharge. The majority of deaths (n=101 [99%]) occurred in the ICU. Conclusion: Our study confirms that TBI is associated with clinically important functional morbidity and mortality. Few patients received seizure prophylaxis or had an ICP monitor placed. These management strategies represent a potential opportunity for improved guideline adherence and will be the focus of a subsequent quality improvement initiative. Introduction: The administration of intravenous fluids is nearly ubiquitous in hospitalbased care, especially in the intensive care unit (ICU). The most widely used intravenous fluid, normal saline (NS), contains a supraphysiologic concentration of chloride, can lead to metabolic acidosis and has been associated with an increased risk of acute kidney injury when given in large volumes. 1,2 Balanced fluids have a lower chloride concentration that more closely matches that of human plasma and there is emerging evidence that their use may be associated with improved outcomes compared to NS. 3 Although there are a number of different balanced crystalloids, all with different electrolyte compositions, studies examining comparative effectiveness amongst these fluids are limited. Objectives: The objective of this systematic review and meta-analysis is to summarize the randomized controlled trials (RCTs) comparing two or more balanced crystalloids. We examined metabolic outcomes (change in serum chloride, potassium, lactate, pH, and base excess) and patient-important outcomes (acute kidney injury, organ failure, need for life support, length of ICU or hospital stay, and hospital mortality). Methods: We performed a comprehensive search of MEDLINE, EMBASE, PUBMED, and CENTRAL. For comparisons with sufficient data, we conducted meta-analysis using inverse variance method and random effects model. We present results as mean difference (MD) with associated 95% confidence intervals (CIs). For comparisons or outcomes with insufficient data to allow pooling, we describe narratively. Results: Of 22669 initial citations, we included 18 RCTs which studied Plasmalyte, Ringer's Lactate, Ringer's Acetate, Ringerfundin, Hartmann's solution, Ringer's Bicarbonate and Sterofundin. Of the included studies, 11 were performed in the perioperative setting, 5 in the ICU, one in the emergency department, and one with healthy volunteers. Volumes of study fluid received ranged from 380 to 19626 mLs. Administration of Plasmalyte resulted in a lower post-infusion serum chloride concentration (MD 1.25 mmol/L lower, 95% CI 0.62 to 1.88 mmol/L lower), and higher post-infusion base excess (MD 0.70 mmol/L higher, 95% CI 0.11 to 1.30 mmol/L higher) compared to any other balanced crystalloid comparator. There were no important differences in post-infusion serum pH, lactate or potassium comparing Plasmalyte to other balanced crystalloids. Data on patient-important outcomes was sparsely reported and heterogenous which did not allow for pooling. Conclusion: This systematic review and meta-analysis demonstrates that administration of Plasmalyte results in lower serum concentrations of chloride and higher base excess as compared to other balanced crystalloids. The certainty of these results are low as studies included heterogeneous populations, there were issues related to risk of bias as well as important imprecision for most outcomes. If balanced crystalloids are found to be beneficial compared to NS, future data examining comparative effectiveness amongst these fluids will be crucial. Introduction: As the COVID-19 pandemic unfolded, the need for a pediatric triage framework for the whole of Ontario became evident. Early data pointed to an adult burden of COVID-19; two factors made a pediatric pandemic triage framework critical: 1) pediatric resources may need to be repurposed for adult care, 2) rapid evolution of resource scarcity highlights a need for a framework when a pediatric focused pathogen might occur. Objective: To establish a pediatric pandemic triage framework that invokes anticipated mortality, baseline morbidity, and anticipated resource utilization in order to identify those patients who would be excluded or removed from intensive care support. Methods: A literature review of adult and pediatric triage plans and consultations with PICU, NICU and bioethics colleagues were undertaken. A utilitarian view (saving the most lives, when not all lives can be saved) was prioritized based on consensus and broad support within the literature, and we initiated an iterative process of expert pediatric critical care consideration for broad categories. Legal and hospital administration provided input. We achieved consensus for reasonableness of the framework from the 4 PICU and 8 NICU stakeholder groups in Ontario. Each group had additional discretionary input from local bioethics, legal, and hospital administrative expertise. Results: Two tiers were chosen to reflect any escalation in resource scarcity ( Figure  1 ). Projected use of scarce resources (ventilators, extracorporeal life support) and mortality were major triage factors, since prolonged single-patient use of such resources -even with almost certain survival -could exclude multiple other patients from life-saving therapies. With high survival rates in general PICU/NICU populations, and relatively short anticipated length of stay, most patients would meet inclusion rather than exclusion criteria for ICU services. Thus, we also mapped out a triage algorithm ( Figure 2 ); we established a first-come, first-served allocation to be used in such cases. No PICU/NICU patient subgroups were excluded, including patients with chronic comorbidities. While scoring tools are elusive in pediatric patients, mortality risk (with and without invasive support) is increasingly well understood by pediatric and neonatal critical care experts and allows anticipated survival to be incorporated in the framework. Additionally, we ensured that exclusion would not be predicated upon disability per se, or perceived quality of life, given the wide range of quality of life outcomes enjoyed by children and their families. Importantly, latitude would be required for decisions specific to unique disease processes. Our framework includes a model for triage team composition, including clinical, administrative and Bioethics expertise to reach rapid and transparent consensus decisions, with an appeal process where appropriate. Conclusion: Ultimately, pediatric triage during a pandemic is an inherently fraught process; our transparent and accountable framework for such decisions may help mitigate moral distress, and will allow a fair process in the worst-case scenario. To solve this problem, the Canadian government issued a call to action from manufacturers to help with the production of PPE. Objectives: To describe the creation of a distributed manufacturing network to address shortages of face shields in long term care facilities, shelters and health centers in the province of Alberta. Methods: Between March 16 and June 21 2020, Alberta 3D PPE operated with the goal of manufacturing and donating reusable face shields to long term care facilities, shelters and health centers in the province. The organization is a public-private-civilian partnership between healthcare providers, industrial designers, engineers, local business with expertise in medical device manufacturing, and the local 3D printing community. Production of face shields began after a 4-week period of team building, design selection, feedback from frontline healthcare providers and Infection Prevention and Control specialists, approval of decontamination protocols, Health Canada licensing and establishment of quality control procedures. Face shields were assembled from a 3D printed headband, a clear plastic visor, closed cell foam padding and an elastic head strap. Delivery was by pickup, courier or shipping. Public and media relations were managed by a University intern. Data on the organization's activities were collected for the period April 13 -June 21. Orders and production were tracked through Google Forms and Google Sheets (Google, CA). Membership was tracked using Slack analytics (Slack Technologies, CA) and active membership was defined as posting or reading in one of the organization's channels. Data on COVID-19 infections were obtained from the Alberta provincial website. Results: During the 10 week data collection period, 2321 face shields were produced with 28 volunteers contributing to the 3D printing efforts. Peak production was achieved by week 4, with 778 face shields produced (Fig 1) . Production mirrored infections in Alberta with a lag time of 2 weeks, as weekly COVID-19 cases peaked in the week of April 20. Production kept up with demand throughout the project. A total of 2177 face shields were ordered and 2071 were delivered based on predetermined criteria, with the highest number (515) in the week of May 25. The majority were from the Edmonton zone (1782, 88%) with less from Calgary (150, 7%), North (61, 3%) and Central (38, 2%) zones (Fig 2) . 1380 face shields (68%) were ordered for assisted living and emergency lodging facilities including long term care, shelters, and seniors' residences. 341 (17%) were for community outreach organizations. 306(15%) were for outpatient medical care, including pharmacies, dental care, and optometry. 44 (2%) were for inpatient settings including emergency departments, diagnostic imaging, and hospital laboratory settings. 157 volunteers participated over the 10-week period. Active membership peaked at 110 members in the week of April 20. Conclusion: A public-private-civilian partnership model of distributed manufacturing through 3D printing was able to nimbly ramp up and ramp down production in response to demand that mirrored rising and falling COVID-19 cases in Alberta. The model represents a viable template for the efficient production of personal protective equipment at a regional level. 

Shahiri T, Shiva Introduction: Maintaining optimum analgesia in anesthetized or sedated patients is challenging due to inability to self-report pain or to exhibit pain-related behaviours. Inadequate analgesia is associated with complications such as persistent postoperative pain and risk of developing chronic pain (1, 2) . When only physiologic parameters are available, the measurement of nociception, the physiological process of encoding noxious stimuli (3), is indicated. The Analgesia Nociception Index (ANI) and the Nociception Level Index (NOL) are innovative technologies for nociception assessment and were selected for this review. The NOL is based on the simultaneous analysis of multiple parameters and their time derivatives, i.e., heart rate (HR), heart rate variability (HRV), photoplethysmography pulse wave amplitude, skin conductance level, its fluctuations, skin temperature. The ANI analyzes the high frequency spectrum of a single parameter, the HRV. These technologies were largely validated in perioperative care; however, the evidence is scarce in the ICU context where the prevalence of sedated critically ill adults is high (4) (5) (6) . Objectives: This review addressed the following research question: "What are the validation strategies used for the ANI and NOL for nociception assessment in anesthetized and sedated surgical patients?" The objectives were to describe the validation strategies and findings from studies for intraoperative nociception measurement with the ANI or NOL in this patient group. Methods: A systematized review was conducted using a comprehensive search in four databases (MEDLINE, Embase, CINAHL, and PsycINFO) from their date of inception to January 28, 2020. The main search terms were nociception measurement, ANI, NOL, validation studies, and reproducibility. A quality assessment using an adapted GRADE approach for measurement tools (7), and a risk of bias assessment using QUADAS-2 tool (8) for diagnostic accuracy were performed by two reviewers. Discrepancies were discussed with a third reviewer to reach consensus. Results: Out of 525 results, a total of 14 validation studies from 9 countries in 4 continents were included. Strategies included hypothesis testing, discriminative validation, and criterion validation (9) . According to hypothesis testing, significant changes in ANI/NOL values were found in response to nociceptive stimuli at different opioid concentrations. Discriminative validation was supported with significant changes in ANI/NOL values between their responses to nociceptive stimuli (e.g., intubation, skin incision, tetanic stimulation) and a non-nociceptive period. Criterion validation was examined to detect nociceptive stimuli (used as the reference criterion) for the ANI and NOL with areas under the curve ranging from 0.83-0.99. Both technologies performed superiorly to traditional HR and blood pressure monitoring in detecting the nociceptive stimuli. Conclusion: Hypothesis testing, discriminative, and criterion validation strategies are deemed appropriate for the testing of the ANI and NOL technologies. Nonetheless, in the absence of a gold standard, the criterion validation should be interpreted with caution. Moreover, reliability could be examined using the test-retest approach, as to expecting consistent values during a stable time interval (9) . Future validation testing of these technologies in sedated/mechanically ventilated patients may support their use in the ICU context.

Sauthier, Nicolas 1 ; Bouchakri, Rima 1 ; Carrier, François-Martin 1 ; Chassé, Michaël 1 1 Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM), Montréal, Quebec, Canada Introduction: Despite a slow improvement in total organ donors over the last 20 years 1 , organ donation is still not meeting the demand. Organ transplantation depends on potential organ donor identification which is still a major challenge. Retrospective studies show that we may miss between 30% and 50 % of potential organ donors [2] [3] [4] [5] . By increasing the total number of potential donors referred to an Organ Donation Organization (ODO), the number of organ donors could substantially increase. Objectives: We aimed to develop a deep learning 6 model using only routinely collected data that could help with the screening of potential organ donors. We present the development and validation of that model. Methods: The model was derived using the electronic health record data from intensive care unit (ICU) stays from Jan 1st 2012, until Dec 31th 2019, in the CHUM (Montreal University Hospital Center, Montreal). We defined our organ donor population as (1) organ donors that were identified in the study institution (2) potential organ donors referred to the ODO but deemed ineligible for transplantation and (3) non-referred potential organ donors identified from manual chart review death audit. We included all laboratory analyses as well as the presence/absence of head scan. We developed a two-step model. First, we trained a deep convolutional neural network 7 autoencoder (CNN-AE) 8 . This model was a non-supervised model that served as an embedding and a dimensionality reduction tool, to reduce noise 9 and for transfer learning and pretraining 10 . The second step was to add a deep classifier to categorize each patient as donor/non-donor. We also implemented a one-layer logistical model (LM), based on the last available value, as a comparator to our neural network (NN) model. The CNN-AE was trained on 85% randomly selected non-donors. The NN model and LM were trained on the rest of the patients, randomly separated in a train (60%), validation (20%) and test (20%) sets. We compared our NN model to our LM using a ROC curve, scaled Brier score and calibration curves 11 with bootstrap for confidence intervals. We manually reviewed the files of patients that were wrongly predicted as donor but who predicted a degree of confidence over 95% in the validation set. 1) . Conclusion: We present preliminary evidence that routinely collected medical data can be used to screen for potential organ donors. When comparing our more complex temporal model (NN) with its non-temporal simpler version (LM) both performed as well globally. However, the NN keeps a good accuracy in the more complex clinical patterns. Prospective and external validation of these models are required for further calibration before any potential clinical application. 

Aoyama, Hiroko Pooled hazard ratios (HRs) for 180-day mortality for individual intervention compared with LPV derived from the primary network meta-analysis showed an advantage for prone positioning and corticosteroids (HR 0.57, 95% Crl 0.25 -1.33 and HR 0.61, 95% CrI 0.21 -1.76, respectively); however, these were not statistically significant. Indirect comparisons among those 6 interventions showed no statistical significance. In post-hoc sensitivity analyses, there was no difference in results by limiting to trials that included only patients with PaO 2 /FiO 2 ratio less than 150 mmHg and no evidence of effect modification based on PaO 2 /FiO 2 ratio using network meta-regression.

This network meta-analysis found that none of 6 prespecified interventions were associated with improved 180-day mortality in patients with ARDS. Strategies to improve longer term outcomes in patients with ARDS will need to employ interventions that are not focused on VILI. Introduction: Sub-phenotypes have been identified in Acute Respiratory Distress Syndrome (ARDS) using plasma biomarkers and clinical data [1] [2] [3] [4] . Preliminary research shows that these sub-phenotypes have the potential for differential prognosis and might predict treatment responses in patients with ARDS. But translation of these models is difficult as a number of the predictor variables employed in these models are not a part of the usual care of ARDS patients and are difficult to ascertain outside the controlled environs of research. Objectives: Development of a model to identify ARDS sub-phenotypes using only routinely available clinical data. Methods: Data available in the electronic health record as a part of routine ARDS care were queried from ARMA-KARMA-LARMA 5-7 (n=473), ALVEOLI 8 (n=537), and FACTT 9-10 (n=1000) for algorithm training. Analysis was performed in python using the SciKitLearn toolkit 11 . 20% of data was of the data was reserved as hold-out. Of the remaining data, 5-fold cross validation with 80/20 train/test ratio was performed. Data was z-scale transformed, and K-means clustering was applied to identify two clusters. Model performance was evaluated on a diverse population including the ART randomized control trial 12 (n=1,013), eICU Collaborative Research database 13 (n=1757), and a consecutive series of adjudicated ARDS patients from the Cleveland Clinic (n=688). Only patients with all required data elements and in-hospital mortality data were included in final analysis. Results: Based on our initial models we identified 2 distinct clusters of ARDS patients. The optimal K-means cluster model included 8 variables which are routinely available from routine care arterial blood gases, multiparametric monitors and serum blood tests. There was a significant difference in the severity of disease among the two clusters, and Cluster 1 patients tended to be sicker, with significantly higher APACHE and SAPS3 scores. Moreover, Cluster 1 patients had higher white blood cell counts, higher serum creatinine and bilirubin, lower platelets, bicarbonate and lower PaO 2 /FiO 2 ratio compared to Cluster 2 patients. Both clusters had similar ARDS etiology rates (Table  1 ). Significant in-hospital mortality differences between clusters were observed between Cluster 1 and Cluster 2 in the training (28.8% vs 17.4%, p <0.00001) and holdout (31.4% vs 16.7%, p=0.00076) datasets. These differences in outcomes were maintained between the two clusters in the validation (49.7% vs 25.4%, p<0.00001) cohort (Table 2) . Limited baseline biomarker data was available for a subpopulation of patients in the ARMA and ALVEOLI training datasets (Table 3 ). There was a clear distinction between circulating biomarkers among the two clusters identified in our cohort. Cluster 1 again exhibited a higher mortality and similar to Calfee et al., with increased circulating levels of IL-6, IL-8, sTNFR1, PAI-1, ICAM1, and VWF. Additionally, Cluster 1 exhibited significantly increased IL-10 and sTNFR2. Conclusion: These findings suggest the potential of an algorithm to sub-phenotype a diverse population of ARDS patients using only data available in the EHR as part of routine patient care. Comparison of mortality, clinical characteristics, and biomarker data with previously published work suggests these sub-phenotypes have similar characteristics to previously published subphenotypes [1] [2] [3] [4] . Table 1  Table 2   Table 3 Introduction and Objectives: Formal interpretation of electroencephalography (EEG) in acute-care units is often performed by trained experts, including neurophysiologists and epileptologists. Owing to the rapid expansion of EEG, delays in formal interpretation are often encountered, with possible implications for patient management. Numerous studies have investigated the role of educational programs to enable non-experts (e.g. nurses and residents) to recognize EEG patterns at the bedside. However, the overall content, structure, duration, and efficacy of these EEG training programs remains unknown. We therefore conducted a systematic review of EEG educational programs for non-experts in adult and pediatric/neonatal acute-care settings (emergency departments (ED) and intensive care units (ICU). Our primary outcome was to describe important similarities, differences, and overarching themes among training programs.

We searched for studies published on MEDLINE, Embase, Cochrane central, CINAHL, and Web of science. To be considered for inclusion, studies were required to present sufficient details of their educational program, including (to the extent possible) content covered, program structure and duration, assessment methods, and trainee experience. Randomized control trials, cohort studies, and descriptive studies were all considered for inclusion. Data was presented in a qualitative manner and organized by theme. Results: Our search yielded a total of 7,034 studies, of which 5,626 were screened. Twenty-six full-length studies met our predefined inclusion criteria. Studies were all published in English and included 23 cohort studies, two descriptive studies, and one RCT. The majority of studies were single center in design and originated in the USA.

One study was performed in the ED, 15 in adult ICUs, four in pediatric ICUs, and six in neonatal ICUs. The majority of EEG training programs were geared towards ICU nurses (16 studies), followed by ICU physicians, and ICU fellows. Most training programs focused on quantitative or processed forms of EEG rather than short/intermittent EEG. By far the most common training program was for amplitudeintegrated EEG (14 studies) followed by color density spectral array (6 studies). EEG education programs involved a mix of large group didactic lectures, small group sessions, and self-learning or one-on-one review with EEG experts. In 16 studies, the overall length of the training program was one day or shorter. Trainee response was positive in the subset of studies reporting this variable.

The majority of EEG training programs involve ICU nurses, quantitative EEG, and are relatively short in duration. Such data could inform future EEG curriculum design for non-experts in acute-care settings. Introduction/Background: Donation after circulatory death (DCD) has been practiced in Canada since 2006 in patients with poor prognosis without hope of meaningful recovery. 1 In DCD, death determination precedes organ recovery and occurs at 5 minutes following permanent cessation of circulation 1 . This approach assumes corresponding permanent cessation of brain activity, but objective data to support this assumption is lacking. In the absence of objective data, current DCD approach risks unnecessary damage to donated organs, or unnecessary suffering of organ donors, if brain activity ceases earlier or later than expected. Objectives: In patients who progress to death following withdrawal of life sustaining measures (WLSM), we aimed to 1) establish the feasibility of monitoring cerebral electrical activity, and 2) examine the temporal association between cessation of brain activity and cessation of cardio-circulatory function. Methods: We enrolled adult patients from the local cohort of the Death Prediction and Physiology after Removal of Therapy (DePPaRT) study at Western University. In addition to DePPaRT physiological monitoring (electrocardiogram, arterial blood pressure [ABP], plethysmography), we recorded electroencephalographic (EEG) data using the 10-20 International System. Data were recorded from the start of the WLSM and until 30 minutes following circulatory arrest. For feasibility outcomes, we reported consent rate. Raw EEG signals were processed to calculate EEG amplitude, frequency, and power spectra over time, and examined by two certified electroencephalographers to determine the time of electrocerebral inactivity. Results: We enrolled eight (5 male) participants with a mean age of 64.3 ± 19.9 years. The consent rate was >80%. Table 1 outlines basic demographic information. Figure 1 shows systemic and neurologic recordings during study procedures in a representative patient. EEG amplitude and frequencies decreased with time from the start of WLSM. Of interest, in five patients there was a surge in EEG power during the dying process. Median time of electrocerebral inactivity was 78.5 seconds (IQR=497.5s) prior to cardio-circulatory cessation. Conclusion: Our study confirms that cerebral neurophysiologic monitoring during the dying process is both technically feasible and acceptable to patients' substitute decision makers. Future studies with larger sample sizes and video-EEG to reconcile potential artifacts are needed to provide more precise estimates. Additional neuromonitoring methods that assess brainstem and cortical function, such as event-related potentials and evoked potentials, should also be considered. These objective neurophysiologic data will inform ongoing work regarding unified brain-based determination of death 3 and inform future DCD practices. Introduction: Extubation failure has been demonstrated to be independently associated with poor clinical outcomes such as increased pneumonia rates and mortality 1, 2 . Although the extubation failure rate is often considered a benchmark for quality assurance in the intensive care unit (ICU), the reported rates of extubation failure are varied, from 2% to greater than 30% 3, 4, 5 . Extubation failure rates and the associated clinical outcomes within adult medical surgical ICUs across the province of Nova Scotia (NS) have not yet been described. Objectives: This is a descriptive study of extubation failure in 12 medical surgical ICUs in NS. Methods: All visits to 12 adult medical-surgical ICUs in NS between April 1, 2018 and March 31, 2020 that involved invasive ventilation were analyzed. Extubation failure was defined as requirement for invasive ventilation within 48hours of extubation. For each visit, data on patient demographics, transfer status, APACHE IV score, ventilation, delirium, mortality, and length of stay was obtained from the NS Provincial ICU database. The NS Provincial ICU database has prospectively captured data since April 1, 2018 for all patients admitted to one of the 12 adult ICUs in the province. Characteristics examined include demographic variables, ventilation characteristics, clinical characteristics, and outcomes. Results: A total of 10,028 ICU visits were recorded from April 1, 2018 to March 31, 2020. During this time, 3,049 ICU visits had at least one episode of invasive ventilation (30.4% of ICU visits in NS). A total of 3197 extubations occurred during the study period, with 236 extubation failures (7.4% extubation failure rate). In the population of patients who failed extubation, median age was 65yrs (min 21yrs, max 92yrs, IQR 17yrs), 42% were female, average Acute Physiology and Chronic Health Evaluation (APACHE) IV predicted mortality was 36.31%, hospital mortality was 30.9%, and standardized mortality ratio (SMR) was 0.85. In patients requiring reintubation, 70.1% were delirious at some point in their ICU stay. Median time on invasive ventilation was 7days (IQR 8.88 days). Median time to reintubation from extubation was 12.6hours (IQR 21.2hours). In the patients that were extubated and did not require reintubation, median age was 63.5yrs, (min 16yrs, max 98yrs, IQR 20yrs), 40.8% were female, APACHE IV predicted hospital mortality was 35.7%, hospital mortality was 32.6%, SMR 0.91. In patients who were extubated and did not require reintubation 36.2% were delirious at some point in their ICU stay. Median time on invasive ventilation was 1.45 days (IQR 2.9 days). There were no significant differences in the demographic variables of patients who fail extubation and those that do not. Patients who fail extubation are more likely to be delirious (70.1% vs 36.2%) and have longer time on invasive ventilation. Conclusions: This is the first descriptive study of extubation failure in NS ICU patients. Invasive ventilation occurred in 30.4% of ICU visits in NS, and 7.4% of all extubations result in the requirement for reintubation within 48 hours. Most extubation failures occur within 12hours of extubation. The higher rate of delirium in patients who fail extubation indicates that extra caution should be taken to observe delirious patients who are extubated. Further analyses are required to help determine predictors of extubation failure in ICU patients in NS. Introduction: The COVID-19 (C19) pandemic has led hospitals to implement restricted visiting policies. While important to minimize viral transmission, limiting family presence for dying patients may have consequences for all stakeholders. The 3 Wishes Project (3WP) is a clinical program with the goal of personalizing the dying process for patients and their families which has been shown to foster meaningful connections among patients, relatives and clinicians and ease family grief. Objectives: To evaluate whether the 3WP is feasible and valuable for patients during the pandemic in 3 units at St. Joseph's Healthcare in Hamilton, Ontario. In this analysis, we focus on findings related to visiting restrictions at the end-of-life (EOL) from the perspectives of clinicians. Methods: In an embedded mixed-methods study, we enrolled patients who had >95% probability of death or plans to withdraw life support. We recorded patient, wish and clinician characteristics. We interviewed clinicians who cared for >1 patient within 2-10 weeks of each death; transcripts were analyzed using a qualitative descriptive approach. Results: From March 16-July 1, 2020, 45 medical patients were enrolled in the 3WP in the ICU (n=34); COVID ward (n=7) or medical step-down unit (n=4). Pre-hospital living arrangements were: home (27, 60%), assisted care (10, 22%), congregate setting (4, 9%) and other hospital (4, 9%). Almost half the patients 20(44%) had family at the bedside at the time of death. Of families unable to visit, 13(52%) already said goodbye, 2(8%) were geographically distant, 3(12%) had personal comorbidities, 1(4%) were at high risk of contracting COVID-19, and 5(20%) did not arrive in time before their loved one died. Although terminal wishes were most commonly those of families (159, 67% wishes), most implemented wishes were facilitated by clinicians involvement (156, 89%). We interviewed 45 clinicians with 13.7 (11.5) [mean (SD)] years of clinical experience conducted by Zoom (n=25) or phone (n=20). Analysis identified 3 themes related to the influence of family member presence on clinicians: a) Clinicians 'filling the gap' for patients when their relatives were not at the bedside. Strategies included increased clinician bedside presence when possible, more sensory stimulation to ensure connections (tactile, auditory and gustatory), and providing enhanced emotional, spiritual and physical support. b) Clinicians assuming the role of 'life line,' connecting families to patients. Liaising with relatives on the phone, clinicians recounted being the voice to relay loving sentiments or express terminal goodbyes. Holding tablets during family videoconferences, clinicians were distressed bearing witness to the angst of separation. c) Implications for future care. Clinicians emphasized the importance of sharing EOL details if families were interested (e.g., patient comfort, clinician bedside presence), family gratitude for terminal wishes including keepsakes as tangible legacy items (e.g., fingerprint key chains, locks of hair), and concern for complicated grief in family members during the pandemic. Conclusions: During the pandemic, the restricted presence of family members at the EOL informed more intentional ways to support dying patients and their families, generating lessons that can inform care of future patients with distant relatives and in future pandemic waves.

Ratano, Damian 1, 4 ; Zhang, Binghao 2 ; Chan, Timothy C.Y. 2 ; Goligher, Ewan C. We propose a lung and diaphragm protective ventilation (LDPV) strategy targeting a dynamic transpulmonary pressure (DP L ) <15cmH 2 O, an esophageal pressure swing (DPes) of -3 to -8 cmH 2 O, and a pH>7.25. Meeting these targets at the bedside may be complex. We implemented a recently developed physiologically based mathematical model 3 to simulate how patients respond to changes in ventilation, sedation, and extracorporeal CO 2 removal (ECCO 2 R) to determine which patients could theoretically reach the goals of the LDPV strategy. Objectives: To estimate the proportion of patients in whom the LDPV target values can be achieved, to determine whether the application of ECCO 2 R substantially increases the probability of reaching the targets, and to identify which patients may require ECCO 2 R to achieve the LDPV goals. Methods: We simulated a population of 100 patients with randomly selected baseline physiological characteristics. The main inputs to the model were PaO 2 , lung (C L ) and chest wall (C CW ) compliance, airway resistance, intrinsic PEEP, V CO2 , alveolar dead space fraction (V Dalv /V T ), respiratory rate, and the strong ion difference (SID). These patients were submitted to titration of ventilation and sedation to achieve targets according to a pre-defined algorithm. Patients who were unable to meet the LDPV targets were submitted to gradually increasing levels of ECCO 2 R and then the algorithm was re-run. The characteristics of the patients succeeding LDPV with or without ECCO 2 R were analyzed in a univariate analysis. Paired sampled t-tests and Wilcoxon rank sum test were performed to determine the effect of variables on the algorithm performance and on the algorithm performance after the use of ECCO 2 R, respectively. p-value <0.05 are significant. Results: Of 100 simulated patients (Table 1) , 49 patients reached the targets of LDPV without requiring ECCO 2 R (15 at baseline, 34 after applying the algorithm). In the 51 patients who failed, none could reach the DP L target and 23/51 could not reach the DPes target. LDPV failure was associated with higher alveolar dead space (0.41 vs 0.27, p<0.001), lower lung compliance (44 vs 53 ml/cmH 2 O, p=0.0013) and greater metabolic acidosis (strong ion difference 34 vs 37 mEq/l, p<0.049). Of the patients who failed, the application of ECCO 2 R enabled 40/51 patients to meet the targets at a median CO 2 removal rate of 30% of V CO2 (IQR 17.5-50) from baseline. Eleven patients could not reach LDPV targets even with ECCO 2 R. The main determinants of failure after ECCO 2 R were higher V Dalv /V T (0.59 vs 0.37, p<0.0001) and lower C L (34 vs 45 ml/cmH 2 O, p=0.011) (Figure 1) . Conclusion: In this in silico clinical trial, LDPV targets could be achieved in 49% of our simulated population. ECCO 2 R increased the probability of reaching the targets of LDPV from 49% to 89%. The main determinants of failure of LDPV strategy are decreased lung compliance and an increased alveolar dead space to tidal volume ratio. Introduction: During the 1950s, the advances in technology within critical care medicine, particularly mechanical ventilation, cardiopulmonary resuscitation (CPR), and the innovations in the practice of organ transplantation together altered the relationship between organ failure and death. Since then, there has been a shift away from the traditional cardiopulmonary death criteria to a brain-based criteria. However, much of the academic literature has been dedicated to the controversy surrounding the definition and determination of brain death. Yet clinically, the determination of brain death in critically ill patients is practised worldwide and seemingly highly accepted by clinicians. Objectives: To develop a comprehensive description of the current understandings of healthcare professionals regarding the meaning, definition and determination of death. Methods: This scoping review was conducted in compliance with the PRISMA-ScR checklist 1 . Online databases were used to identify papers published from 2003 to 2020. Additional sources were searched for conference proceedings and theses. Two reviewers (SS & KZ) screened the papers using predefined inclusion and exclusion criteria, extracted data for specific content variables and performed descriptive examination. Complementary searches and review of reference lists were used to complement the final study selection. A search strategy using vocabulary of the respective databases was created, and criteria for the inclusion and exclusion of the articles was established. A data extraction instrument was developed to iteratively chart the results of the review. A qualitative approach was conducted to thematically analyze the data. Results: We screened a total of 4935 papers, of which 64 met the full inclusion criteria. Fifteen additional papers were added from complementary searches, totalling 79 papers overall. Identified themes included: 1) the historical evolution of brain death, 2) persistent controversies about brain death and death determination, 3) wide variability in healthcare professionals' knowledge and attitudes about death determination, 4) critical need for brain death determination revision. Conclusion: We concluded that although brain death is widely accepted, there exists variation in healthcare providers' understanding of its conceptual basis. Death determination remains a divisive issue among scholars. This review found there is a need for increased opportunities for formal training on brain death among healthcare providers. Nasopharyngeal pressure was measured using a dedicated 12 French catheter, as well as esophageal pressure (Cooper catheter). Tidal volume and flow were estimated using calibrated electrical impedance tomography (Pulmovista). We calculated the pressure-time product of the respiratory muscles, inspiratory and expiratory resistance. We used Friedman test and Nemenyi post hoc test, two-way ANOVA and Bonferroni post hoc test.

The bench data simulating mouth closed showed that pressure increased with flow up to 4 cm H2O while a progressive reduction in tidal volume was observed with increasing flow. The study in healthy subjects showed a nasopharyngeal pressure at 60L/min close to 7 cmH2O with mouth closed, higher than CPAP; a decrement in respiratory rate (by lengthening expiration) and a relative worsening of mechanic, with no change in tidal volume. The decreased rate explained a reduced effort (pressure time product). With mouth closed we observed an increased resistance to breathing, both inspiratory and expiratory. Mouth open showed much less pressure and physiological effect of HFNC. Conclusions: During HFNC, strictly closing the mouth can result in increased resistance to breathing both in a bench and in a healthy volunteer study. In healthy volunteers with moth closed, HFNC at a flow of 40L/min delivers pressures comparable to CPAP 4cmH2O, whereas at 60L/min it delivers pressures close to 7 cmH2O. The increase in inspiratory and expiratory resistance might explain the decrease in respiratory rate and the prolonged expiration. were not significantly associated with post-operative delirium. There were no measurable, systematic differences between sites that predicted delirium. Adjusting for intraoperative medications did not improve model performance in predicting delirium after adjusting for known covariates (χ 2 = 0.551, p = 0.908). Conclusion: Intraoperative benzodiazepine, dexmedetomidine or opioid administration or dose were not associated with an increased risk for delirium after cardiac surgery.

Klowak, Jennifer A Background: Status epilepticus is a common neurologic emergency in children with potentially devastating outcomes. Approximately one third of patients do not respond to first-line treatment. 1 The most effective and safe second-line agent remains unclear. Objective: To synthesize the available evidence examining the efficacy and safety of levetiracetam compared to phenytoin or fosphenytoin in benzodiazepine-refractory pediatric status epilepticus. Methods: We searched (from inception until April 27, 2020) Ovid MEDLINE, EMBASE, Web of Science, and Cochrane Central Register of Controlled Trials (CENTRAL) for randomized controlled trials (RCTs). Two reviewers, independently and in duplicate, screened citations to identify eligible RCTs that compared levetiracetam to (fos)phenytoin for benzodiazepine-refractory status epilepticus in children, or had data from a subgroup of children. Independently and in duplicate, we performed data abstraction, risk of bias (RoB) assessment using the Cochrane RoB tool and certainty assessment using GRADE. We performed meta-analyses using random-effect models or presented findings narratively if there were insufficient data for quantitative analysis. Results: We identified 7 RCTs (n = 1,575) [2] [3] [4] [5] [6] [7] [8] . Four RCTs used phenytoin and 3 used fosphenytoin as the comparator. Pooled analysis demonstrated low certainty evidence of no difference of levetiracetam on time to seizure cessation (mean difference -3.11 minutes, 95% confidence interval (CI) -6.67 to 0.45), early seizure cessation (relative risk (RR) 1.09, 95% CI 0.95 to 1.26) or late seizure cessation (RR 1.05, 95% CI 0.93 to 1.18) as compared to phenytoin or fosphenytoin. In general, adverse event outcomes were not consistently reported, and our conclusions are limited by imprecision due to low numbers of events. We found low certainty evidence for less respiratory depression with levetiracetam (RR 0.28, 95% CI 0.12 to 0.69).

The efficacy of levetiracetam is comparable to phenytoin or fosphenytoin in children with benzodiazepine-refractory status epilepticus (low certainty evidence). Levetiracetam may cause less respiratory depression. Clinicians and guideline developers should weigh safety profiles and practical considerations when choosing between these agents. Background: Lung protective ventilation (PV) using low tidal volumes (Vt) and high positive end-expiratory pressure (PEEP) has been advocated in organ donors (OD) to increase the rate of lung procurement. Although one randomized-control trial (1) and observational studies support this approach, PV was part of a larger bundle of shortterm interventions, and its contribution to the observed benefits is not well understood. Furthermore, a recent large French cohort study showed that this approach, even if it increased procurements, is applied in less than in 30% of ODs at the time of lung proposal (2) . A better understanding of the ventilatory settings and interventions in this population could inform future studies. Objective: Our first aim was to determine the frequency and how PV was achieved for ODs in our center. Our second aim was to describe the overall characteristics of the respiratory mechanics at the beginning and at the end of the lung support process in our population. Results: Among 222 potential ODs after NDD, 184 gave organs, of which 145 were supported for potential lung procurement and 90 finally procured (62%). The majority were males (75%), with a mean age of 50 ± 18 years old and a BMI of 27.3 ± 5.5. The median duration of intubation was 3 days (IQR 2;4), the median duration of support after NDD was 25 hours (IQR 18;35) and the principal modes of ventilation were volume Control (56%) or pressure Control (40%). Recruitment maneuvers were done at least once in 67% and twice in 48% of the cases (no difference between lungs procured or not). As displayed in Table 1 , median Vt was 8.3 (7.5;9.5) mL/kg and PEEP = 5 (5;8) cmH 2 O at T0 vs 8.7 (10.7;10.2) mL/kg and PEEP = 8 (5;10) cmH 2 O at T1. Vt was set at ≤ 8 mL/kg in 40.5% at T0, but decreased to 34.6% at T1 (p>0.5), which is driven by the group with lungs that were not procured; in contrast PEEP was set > 8 cmH 2 O in 32.6% at T0 and increased to 64.9% at T1 (p<0.001). In all groups the median PPLAT and Driving Pressure did not change significantly between T0 and T1 ( Table 2 ). Comparing procured and non procured lungs, the proportion of PV (for Vt and PEEP) showed no differences (Table 1) . However, the P/F ratio was higher both at T0 and at T1 for the procured lungs (Table 2 ), in addition to a significant improvement during support (Delta P/F= 92), which could suggest the effect of other interventions Conclusion: In our cohort, a small proportion of ODs were exposed to the low Vt aspect of PV, and more frequently to the higher PEEP. According to Driving Pressure and PPLAT, the ventilation remained "protective", which might be due to alveolar recruitment. The better Delta P/F ratio observed in the procured lung group deserves further analysis to determine the interventions responsible for P/F improvement. Table 1   Table 2 , however large randomized controlled trials (RCTs) are ongoing 3, 4 . Even more uncertainty remains regarding optimal crystalloid in the setting of diabetic ketoacidosis (DKA), a condition in which often requires large volume resuscitation and challenging electrolyte management. This systematic review and meta-analysis summarize the effect of BES versus NS in DKA patients. Methods: We performed a comprehensive search of MEDLINE, EMBASE and Cochrane library. We included RCTs that compared BES vs NS in DKA patients. We pooled estimates of effect using relative risk (RR) for dichotomous outcomes and mean differences (MD) for continuous outcomes with 95% confidence intervals (CIs). We assessed risk of bias for included RCTs using a modified Cochrane tool and certainty of evidence using GRADE methodology. Results: We included 6 RCTs (n= 324 patients). There was no important difference in DKA resolution (RR 1.00, 95% CI 0.94 to 1.05, moderate certainty) or post resuscitation serum chloride (MD 1.44 mmol/L higher, 95% CI 1.74 lower to 4.63 higher, moderate certainty) and an uncertain effect on mortality (RR 0.66, 95% CI 0.14 to 3.13, low certainty) when using NS compared to BES. Time to DKA resolution was likely longer in the NS group (MD 3.12 hours longer, 95% CI 0.30 shorter to 6.53 longer, moderate certainty). NS use was associated with a lower post resuscitation serum bicarbonate (MD 1.77 mmol/L, 95% CI 0.27 lower to 3.27 lower, moderate certainty) and longer hospital stay (MD 0.87 days longer in NS group, 95% CI 0.30 days longer to 1.45 days longer, moderate certainty) compared to BES. Complications from IV fluids were rare and rates were similar between each type of fluid. Conclusion: In patients with DKA, there was no difference between NS and BES in terms of DKA resolution or serum chloride, with an uncertain effect on mortality. NS may be associated with longer time to DKA resolution, lower post-resuscitation serum bicarbonate levels and longer hospital stay compared to BES. 1,2 Apart from dealing with emotional burden of the patient's critical illness, having to make difficult decisions on behalf of the patient is an additional stress for a family caregiver. 3 Delirium is frequently experienced by patients in the ICU 4 and is distressing to patients and family caregivers. Family caregivers of critically ill patients are reported to have long-lasting negative psychological sequalae, including anxiety and depression. We aimed to examine patterns of co-occurrence between anxiety and depression symptoms among family caregivers of critically ill patients with delirium. Methods: Latent class analysis was used to examine patterns of self-reported anxiety and depression symptoms among family caregivers for critically ill patients enrolled in a single-centre validation study conducted at a large academic hospital (Calgary, Canada) in a single-payer healthcare system. Patient-family dyads were included if family member anxiety and depression were assessed at the same time as the first patient delirium assessment. The seven-item Generalized Anxiety Disorder-7 (GAD-7) scale was used to assess self-reported symptoms of anxiety; symptom severity was classified as none, mild, moderate or severe. Patient Health Questionnaire-9 (PHQ-9) was used to assess symptoms of depression; symptom severity was classified as none, mild, moderate, moderately severe or severe. Patient delirium was assessed by the Confusion Assessment Method for ICU (CAM-ICU), a four-item ICU delirium detection tool with high sensitivity (93-100%) and specificity (98-100%). Latent class membership was estimated based on the latent class posterior distribution. Family caregiver age (dichotomized at 65 years) and family caregiver sex were treated as independent variables to predict latent class membership. Two-to five-class models were calculated and compared on Bayesian information criterion values. Results: Three distinct classes for patterns of co-occurrence between anxiety and depression symptoms were identified. Class membership differed by anxiety and depression symptom severity. Among 40 family caregivers (median age 53 years [IQR 44-63 yr]; 80% female), the classes identified were (1) no anxiety/no depression; (2) mild-moderate anxiety/mild depression; and (3) severe anxiety/moderate-severe depression. Among 92 family caregivers for critically ill patients without delirium (median age 57 years [IQR 46-67 yr]; 72.8% female), the classes identified were (1) no-mild anxiety/no-mild depression; (2) moderate anxiety/moderate depression; and (3) moderate-severe anxiety/moderate-severe depression. Class membership for all caregivers (N=132) was significantly predicted (p<0.05) by family caregiver age (class 1 versus class 3) and family caregiver sex (class 2 versus class 3). Conclusion: Our findings contribute to knowledge on co-occurrence patterns of anxiety and depression among family caregivers of critically ill patients. The mental health of family caregivers of critically ill patients with delirium may require different targets in mental health interventions. These findings lay the foundation to assess overlapping trajectories for anxiety and depression symptoms and may inform future mental health treatments.

Bednarek, Olga Lucia 1 ; Jessula, Samuel 1 ; Minor, Samuel Fulton 1 1 Department of Critical Care Medicine, Dalhousie University, Halifax, Nova Scotia, Canada Introduction: In-situ simulation shows promise as an effective multidisciplinary team training tool to identify latent safety errors, optimize communication and system processes. The COVID pandemic has required the rapid adoption of new system processes in the ICU that are ideally evaluated and practiced in the actual care environment. In-situ simulation is an ideal tool for this, however, its disruptive nature is a major downside. Although the benefits of in-situ simulation in the ICU setting have been described, the potential perceived harm to patient care of running an unscheduled simulation using actual working staff are unknown. The aim of this study is to assess the multidisciplinary team member's perceptions regarding the value of insitu simulation relative to its perceived impact on patient care, practicing the transfer of a COVID positive trauma patient from the trauma bay to the ICU. Methods: We conducted a longitudinal survey study including all members of the multidisciplinary ICU team and trauma team at the QEII Health Sciences Centre, a level 1 trauma centre in Nova Scotia. Following an in-situ simulation involving the transfer of a COVID positive trauma patient from the trauma bay to the ICU, participants were given a 10-question survey with answers on a 5 point Likert scale exploring the perceived harms and benefits of the experience. Results: Response rate was 100%, for a total of 43 surveys administered after 4 in-situ simulations that took place at the start of the COVID pandemic. The survey respondents were, attending staff (21%), nurses (21%), paramedics (7%), respiratory therapist (9%) and residents (42%). Respondents felt that participating in the in-situ simulation delayed (28%) or compromised patient care (5%) infrequently. No respondents felt that patients were harmed on account of running the simulation. In-situ simulation was felt to identify important safety issues (70%), improve team communication (89%) and improve patient care (89%). The in-situ simulation was considered enjoyable (92%) and identified as a good educational experience (93%). Conclusions: In-situ simulation is not felt to cause delays or compromise patient care. It is considered to be a good learning opportunity that identifies safety issues and improves patient care. This study can help inform other trauma programs who are contemplating starting in-situ simulations, but are concerned about its possible impact on patient care and team buy in.

Introduction: Evidence has emerged that driving pressure during pressure support ventilation (PSV) is associated with outcome, as in controlled mechanical ventilation [1] . This measurement, however, is not routinely performed, as it requires a reliable assessment of Plateau Pressure (Pplat) during an inspiratory hold. In fact, not all ventilators allow to perform an inspiratory hold during assisted ventilation modes and the interpretation of the result might not be straightforward because of ongoing patient's muscular activity. Nevertheless, the Pplat value can be of invaluable help in clinical practice, both to compute driving pressure under PSV [1] and to monitor patient's inspiratory effort [2] . Objectives: To evaluate the reliability in assessing inspiratory holds performed during PSV as general "readability" (determining if the hold reveals a stable airway Pplat) and as the value and duration of the plateau. Methods: This is an ancillary analysis of pressure and flow curves obtained during a multicenter observational study aimed to describe the incidence of patient-ventilator asynchronies in ARDS patients (BEARDS, NCT03447288). Tracings were evaluated by six independent raters, experienced with ventilator waveforms assessment. We selected tracings with an inspiratory hold and a reliable Pes tracing acquired simultaneously. The raters evaluated the same tracing twice, with and without a Pes tracing available, and in random order (Fig1-2). For each tracing, raters were asked to determine the readability of the plateau (readable yes/no) based on the following criteria: 1) flat plateau 2) zero flow 3) in presence of inspiratory efforts, flat plateau before and after the efforts. For the holds considered readable, the value of the plateau and its duration were measured. Krippendorf's alpha (α) test was used to estimate the interobserver agreement on the general readability of the hold. Intraclass correlation coefficient (ICC) was used to estimate the agreement on continuous variables. α and ICC values >0.75 were considered as good agreement. 

The interobserver agreement in evaluating inspiratory holds during PSV was relatively low, but when an agreement was reached the interpretation of the value and duration of the plateau were very consistent among raters, as well as the intrarater agreement in evaluating the same hold with and without Pes. Further analyses are ongoing to evaluate 1) the main reasons for which holds were not uniformly interpreted 2) the features of readable holds. and have been found to be associated with a number of variables including age, sedation level, tube fixation strategies, nurse-to-patient ratios and patient procedures. 13, 15, 16 To our knowledge, a matched case-control study design has not been used to explored the variables associated with increased risk of UE in critically-ill children. Objective: Our aim was to investigate the association between UE and patient, environmental, and care-related characteristics. Methods: We performed a retrospective case-control study in a Canadian Pediatric ICU (PICU), including children who were admitted between January 2004 -December 2014. Cases included children who experienced a UE during their admission; cases were matched with controls (4:1) who did not experience a UE. Cases and controls were matched by age, sex, and the length of stay in the critical care unit at the time of event; data was obtained using manual review of electronic health records. Univariate and multivariate conditional logistic regression was used to evaluate associations between the exposures (patient, environmental, and care-related characteristics) and the outcome (UE), taking into account the matched study design. Odds Ratios (OR) with 95% confidence intervals (95% CI) were used to represent magnitude of effect. Results: There was a total of 458 cases, and 1601 controls. Children who were nasally intubated had 0.37 (95% CI: 0.29 -0.48) the odds of having a UE, compared to children who were orally intubated. When adjusted for confounding variables such as endotracheal tube sections, restraints, sedation level, muscle relaxation, room set-up and number of previous intubations, the odds ratio remained significant at 0.41 (95% CI: 0.29-0.58). Children who were in a shared room had lower odds of UE compared to children in a single room (OR 0.66, 95% CI: 0.46-0.95). The number of previous intubations in the past two years also significantly increased the estimated odds of UE, even after adjusting for confounders. Discussion: The results suggest that nasotracheal intubations are associated with lower odds of UE when compared to orotracheal intubations, which is consistent with a recent multi-site retrospective review using a large PICU database. 8 Our study provides further evidence by controlling for clinical confounders such as endotracheal tube secretions, restraints and sedation level. Clinicians should weigh this evidence against the possible complications from nasotracheal intubation, such as tissue injury and ventilator associated pneumonia. 8 Our results also suggest that patients in shared rooms had lower odds of UE, which is likely related to the number of clinicians within direct eyesight of the intubated patient. 9 We found that patients who have previously experienced a UE had increased odds of experiencing another UE, which is consistent with adult critical care literature. 10 This study, to our knowledge, is the first matched case-control study assessing risk factors for UE in critically ill children. These findings can help clinicians identify the patients who are at higher risk of UE, increasing patient safety in pediatric critical care. Introduction: It is common medical knowledge that a single unit of red blood cells (RBC) transfusion increases the hemoglobin (Hb) by 10 g/L of (Hb). This practice was recently validated in a big study of over 38000 transfusions 1 in all types of patients. Choosing Wisely Canada recommends to transfuse one unit of RBC in stable anemic patients and wait for an Hb control before transfusion additional units. 2 However, in acute situations where the Hb level is lower than the usual thresholds of 70-80 for RBC transfusion (for example 50g/L), it may be tempting to transfuse two units of RBC to raise the Hb level above that threshold without delay. Objectives: The objective of this study was to investigate the effect on Hb levels of transfusing one RBC unit in stable anemic patients in the critical care unit (CCU). Methods: We conducted a retrospective analysis using the eICU Collaborative Research Database 3 , a multicenter database of CCU admission in 2014-2015. We analyzed transfusions of one RBC unit in adult patients without evidence of hemodynamic instability, recent bleeding or acute ischemic heart issues. We included all transfusions of patients with both pre-transfusion and post transfusion Hb value. First, we analyzed data in a univariate and a multivariate approach, using a generalized linear mixed effect model controlling for gender, age, height, weight, pretransfusion Hb value and reason for admission (specifically bleeding, trauma, surgical or infection). Second, we selected anemic (HB < 60 g/L) patients who received a single order of two units RBC units and used our model to predict the potential posttransfusion Hb if the patient had received one unit instead of two. Results: There were 6308 transfusions of one unit RBC among 4421 patients. The median volume of transfusion was 350 mL (IQR 300-350) for 1 unit. The patients were male (52%) of median age of 66 years old (IQR 54-75) with a median Hb pretransfusion of 72 g/L (IQR 67-82). The Hb variation from pre-transfusion Hb level was non-linear. At baseline Hb of 70 g/L, average Hb variation post-transfusion was 11.4 g/L (95%CI 11.1-11.7) while controlling for age, sex, weight, height, surgical status. Variation was satistically higher in elderly (0.4 g/L/10y female (0.9 g/L) in surgical patients (0.8 g/L), lower body weight (0.5 g/L/10 kg) and smaller patients (0.6 g/L/10cm) but likely not clinically significant. Hb variation increased by 4.0 g/L (CI95% 3.8-4.2) for every 10 g/L decrease of pre-transfusion Hb ( Figure 1) . However, the model explained only 30% of the variance, leaving a standard error on the residual of 9.4 g/L. On the 244 patients with less than 60 g/L of Hb that received two units of RBC, 24.5% still had an Hb of less than 70 g/L after transfusion. If we apply the results of our model to those patients, simulating giving them only one unit instead of two, 41.4% would still had an Hb of less than 7 g/L at control. Conclusion: This study show that in stables CCU patients one unit of RBC increases in average the Hb of 11.4 g/L. This variation is slightly affected by gender, age, height, weight, surgical status and mostly by pre-transfusion Hb level. In the more severely anemic patients that received two units, applying the model showed that although a significant proportion of patients may not reach the target threshold with one unit, more than 50% may not have required a second RBC unit after receiving only one. This supports the recommendation of transfusing only one unit of RBC in anemic and sable patients in the CCU. the pandemic, as many clinicians highlighted its future potential when relatives are geographically distant. c) Losses experienced with technology-mediated communication: Regarding phone and video platforms, clinicians spoke to the loss of human touch, and limited ability to detect non-verbal cues or convey empathy. Fewer opportunities for scheduled or impromptu in-person rapport-building bedside family conversation made clinician-initiated phone calls seem relatively more instrumental, making GOC discussions difficult. d) Video platform cautions and considerations: Clinicians sometimes found video visits technically and/or emotionally difficult for patients, families and themselves. They also wondered if unconscious patients would want to be viewed this way. Loss of privacy with clinician-facilitated virtual visits concerned some clinicians; others were distressed bearing witness to family member angst when seeing their dying loved one on screen for the last time. Conclusions: During the pandemic, the limited presence of family members at the EOL has catalyzed technology-mediated verbal and visual communication. Clinicians identify both gains and losses, sharing cautions and considerations for future practice including pandemic waves. Introduction/Objectives: Quality care at the end of life (EOL) is an espoused right of every Canadian. Among decedents in Ontario, recently immigrated and ethnic minority patients are more likely to die in ICU and receive more aggressive life-prolonging treatment in the last six months of life in comparison to other Canadians [1] . It is not clear whether differences are attributable to diverse preferences for EOL care, or whether they are a result of specific disparities in the quality of care that occur along the EOL trajectory. This observational survey-based analysis seeks to evaluate the quality and provision of EOL care for patients of diverse ethnocultural backgrounds. Methods: The End of Life survey (validated 52-item tool) is routinely administered to next-of-kin of all decedents at Sunnybrook Hospital to measure satisfaction with inpatient EOL care. The primary outcome is the global measure of satisfaction (10point Likert scale). We performed a stratified analysis using modified Poisson regression to identify specific patient ethnic groups with important differences in family satisfaction with quality of EOL care. Secondary predictors of family satisfaction included: patient religion, level of religiosity, primary language, language barriers, care perceived to be consistent with patient wishes and location of death. Univariate Poisson regression was applied to each predictor variable to determine preliminary associations (at p<0.2) for inclusion in the final adjusted model with a significance threshold level of α<0.05. Results: Among 1384 surveys (2012-2019), 21.4% (n=295) of patients were identified as non-Caucasian. Overall, 76.2% of family members of Caucasian patients and 71.9% of non-Caucasian patients were "very/completely satisfied" with the overall quality of EOL care. Family members of patients who died in ICU more likely to be "very/completely satisfied" in comparison to patients who died in other units (p=0.007). There were no differences in rates of dying in ICU among patient ethnic groups. Examining specific ethnicities, family members of Muslim patients and those of Middle Eastern descent were less likely to be satisfied in comparison to other patients (OR 0.81 95%CI 0.60-1.09, p=0.158; OR 0.73 95%CI 0.52-1.03, p=0.073, respectively). The relationship between patient religion (Muslim vs. non-Muslim) and family satisfaction was not significantly influenced by level of patient religiosity (OR 0.76 CI 95% 0.49-1.14, p=0.185). In the adjusted model, family members of patients of Middle Eastern descent had lower satisfaction with quality of EOL care (B=-0.678, SE=0.327, p=0.038). Family satisfaction increased by 2.9x for patients whose care was consistent with their wishes, and decreased by 39.5% for those who experienced language barriers. Location of death (ICU vs. other) was a non-significant predictor of family satisfaction (p=0.087). Conclusions: Our findings suggest that family members of patients who died in ICU were most commonly very/completely satisfied with the quality and provision of EOL, regardless of patient ethnicity or religious background. Dying in ICU setting with more intensive care may therefore not be an appropriate indicator for measuring quality of EOL care for patients and families. Family members of patients from certain ethnic and Introduction: Burnout results from chronically high levels of stress in the workplace and is characterized by emotional exhaustion, depersonalization and reduced personal accomplishment.1 Moral distress occurs when individuals are placed in situations that are at odds with their core values and have little power to make change2. Both have a significant negative impact on healthcare providers, their families as well as patients.3,4 Causes are numerous, however provision of end of life care (EOLC) has been identified as a significant contributor.5-7 Objective: Within our ICU team, previous research quantified high rates of burnout and moral distress.8 The objective of this study was to describe the impact that EOLC has on burnout and moral distress for the team at an academic Intensive Care Unit in Halifax, Nova Scotia. Methods: This qualitative study used focus groups to elicit a better understanding of stakeholder perspectives on EOLC contributing to burnout and moral distress in the ICU team. Research Ethics Board approval was obtained (REB File #1024175, 2019). A thematic analytic approach was used to guide analysis of the data9 with respect to issues, impact and suggestions to build resilience. Results: 6 focus groups, each with 4-8 participants, were conducted. A total of 35 participants (6 MDs, 21 RNs and 8 RTs) represented 43% of the MDs, 18.8% of the RNs and 20.0% of the RTs. EOLC was recognized by all to be a vital aspect of ICU, however, the cumulative frequency with which this occurs was identified as a cause of burnout and moral distress. Compounding the volume of exposure was the lack of time during a shift to process the death of a patient before moving on to caring for the next critically ill admission. Advocating for appropriate goals of care, either in the form of perceived futility or violation of patient autonomy caused significant burnout and distress. These occurred within the medical team and/or between the team and the patient's substitute decision maker. Discordance within the team was in part due to differences in professional roles and responsibilities. In collaboration with families, physicians write the order for withdrawal of life sustaining measures which has an emotional burden and legal responsibility. However, nurses are left to implement a patient care plan which they had little input in establishing and may not agree with. Discord between the ICU team and primary medical provider goals for care was also identified as an issue. EOLC dynamics negatively impacted participant's emotional and physical well-being, their personal relationships as well as delivery of patient care. Many reported feeling isolated as family and friends are ill equipped to provide support. Previous experiences with debriefing sessions held in the ICU were considered very valuable and regular debriefing was suggested to build resilience. Other suggestions include mental health recovery days and destigmatizing the need for help.

Di Santo, Pietro Introduction: Frailty is a syndrome characterized by physiological decline and marked increase in vulnerability to adverse health outcomes. 1 While there is an association between aging and frailty, the two concepts are not synonymous and the gradual decline in physiological reserve seen with aging is accelerated in frail individuals. 2 Frailty is common in patients admitted to medical intensive care units (ICUs) and is associated with worse clinical outcomes. 3 Cardiac intensive care units (CICUs) have evolved in response to an increasingly complex and diverse patient population admitted with acute cardiac pathology. 4 The prevalence of frailty and its association with clinical outcomes among patients admitted to the CICU remains unknown. Objectives: We sought to describe the characteristics and outcomes of patients with frailty admitted to a dedicated CICU. Methods: This retrospective cohort study was performed using the CICU registry at the University of Ottawa Heart Institute -a 14-bed unit servicing a population of ~1.3 million residents in eastern Ontario. All adult patients admitted to the CICU between November 1, 2018 and April 30, 2020 were included in the data analysis. Patients were excluded if they had missing data related to baseline frailty or clinical outcomes. The presence and severity of frailty was assessed prospectively using the Clinical Frailty Score (CFS) 5 at time of admission. In accordance with existing ICU literature 3 , a CFS ≥ five was used to classify a patient as "frail". Baseline demographic data and clinical outcomes were obtained from the registry. Multivariable logistic regression modeling was used to adjust for predefined variables including age, sex, and reason for admission. All statistical analyses were performed using SAS v9.4. Results: A total of 1,642 patients were admitted to the CICU during the study period, of which 1,610 (98.1%) patients had a baseline CFS score available. Of these, 370 (23.0%) patients had frailty. Patients with frailty were older (73.9 ± 12.9 vs. 66.8 ± 14.6 years; p<0.001) and included more female patients (41.1% vs. 33.6%; p=0.03). The admission diagnosis was acute coronary syndrome in 23.5%, heart failure/cardiogenic shock in 28.7%, arrhythmia in 15.1%, and out-of-hospital cardiac arrest in 5.1% of patients with frailty. There was a greater comorbidity burden in the frail cohort ( Figure  1 ). There was no difference in the length of stay in CICU between the groups (4.0 ± 5.7 vs 4.2 ± 5.4 days; p=0.51). Following adjustment for age, sex, and admission diagnosis, patients with frailty were more likely to have cardiovascular death (OR 2.65, 95% CI 1.62-4.34), all-cause death (OR 3.06, 95% CI 1.95-4.81), require non-invasive mechanical ventilation (OR 1.70, 95% CI 1.17-2.47), vasoactive medications (OR 1.69, 95% CI 1.28-2.24), or renal replacement therapy (OR 5.24, 95% CI 3.33-8.26). There was no difference in the need for invasive mechanical ventilation or bleeding complications between the two groups ( Figure 2 ). 

Canadian Institute for Health Information

The third international consensus definitions for sepsis and septic shock (sepsis-3)

Grant Acknowledgement: The study is supported by the Hamilton Health Sciences Strategic Initiative. It is also funded by the CIHR/NSERC Collaborative Health Research Program Grant

Risk Of Inadvertently Cutting In-Line (Closed) Suction Catheters

Organ donation and transplantation in Canada

Attitudes and opinions on organ donation: an opportunity to educate in a Canadian city

Public awareness of organ donation

Health Professional Awareness and Attitudes on Organ and Tissue Donation and Transplantation Including Donation after Cardiocirculatory Death. Canadian Council for Donation and Transplantation

Understanding disparities in donor behavior: race and gender differences in willingness to donate blood and cadaveric organs

Chinese Canadian beliefs toward organ donation

Indo-Canadian beliefs toward organ donation

Views Toward Organ and Tissue Donation and Transplantation

European Directorate for the Quality of Medicines & HealthCare of the Council of Europe

International guideline development for the determination of death

Organ donor management in Canada: recommendations of the forum on medical management to optimize donor organ potential

Consent for organ donation in Canada. Library of Parliament. HillNotes: Research and Analysis from Canada's Library of Parliament

Organ and tissue donation act: an overview. Department of Health and Wellness

The authority of next-of-kin in explicit and presumed consent systems for deceased organ donation: an analysis of 54 nations

Family veto in organ donation in Canada: fracming within English-language newspaper articles

Evaluation of the coverage of linked Canadian Community Health Survey and hospital inpatient records

Sampling: Design and Analysis

Occupation, income, and education as independent covariates of arthritis in four national probability samples

Grieving family of Humboldt victim works to drive up number of Canadian organ donors

ICU Medical Conditions | The Ottawa Hospital

Rapid saline infusion produces hyperchloremic acidosis in patients undergoing gynecologic surgery

Intravenous balanced solutions: from physiology to clinical evidence

Balanced crystalloids versus saline in Critically Ill Adults

Persistent Postsurgical Pain: Pathophysiology and Preventative Pharmacologic Considerations

Prevalence and Characteristics of Chronic Intensive Care-Related Pain: The Role of Severe Sepsis and Septic Shock

International Association for the Study of Pain

Pain Measurement in Mechanically Ventilated Patients with Traumatic Brain Injury: Behavioral Pain Tools Versus Analgesia Nociception Index. Indian journal of critical care medicine: peerreviewed, official publication of Indian Society of Critical Care Medicine

Exploration of the Nociception Level (NOL™) Index for Pain Assessment during Endotracheal Suctioning in Mechanically Ventilated Patients in the Intensive Care Unit: An Observational and Feasibility Study

Analgesia nociception index for the assessment of pain in critically ill patients: a diagnostic accuracy study

A Validated Approach to Evaluating Psychometric Properties of Pain Assessment Tools for Use in Nonverbal Critically Ill Adults

QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies

Health measurement scales: a practical guide to their development and use

Annual Statistics on Organ Replacement in Canada: Dialysis, Transplantation and Donation

Donation after cardiocirculatory death in Canada

Variability in the determination of death after cardiac arrest: a review of guidelines and statements

Circulatory Arrest, Brain Arrest and Death Determination. Frontiers in Cardiovasc Med

Extubation Failure in Intensive Care Units in Nova Scotia: A Descriptive Study Chang

The effect of reintubation on ventilator-associated pneumonia and mortality among mechanically ventilated patients with intubation: A systematic review and metaanalysis

Outcome of reintubated patients after scheduled extubation

The Decision to Extubate in the Intensive Care Unit

Project TQI in CC. Quality Improvement in Critical Care: Selection and Development of Quality Indicators

Cumulative Probability and Time to Reintubation in United States Intensive Care Units

Physiologic Effects of High-Flow Nasal Cannula in Acute Hypoxemic Respiratory Failure

Nasal high-flow therapy delivers low level positive airway pressure

Intraoperative Predictors of Delirium Post Cardiac Surgery: Analysis of the B-References

Diagnostic and statistical manual of mental disorders (DSM-5®)

Effect of intensive care unit environment on in-hospital delirium after cardiac surgery. The Journal of thoracic and cardiovascular surgery

Early delirium after cardiac surgery: an analysis of incidence and risk factors in elderly (≥ 65 years) and very elderly (≥ 80 years) patients

Derivation and validation of a preoperative prediction rule for delirium after cardiac surgery

Postoperative delirium in older adults: best practice statement from the American Geriatrics Society

Cognitive trajectories after postoperative delirium

Effect of delirium and other major complications on outcomes after elective surgery in older adults

Is intravenous lorazepam really more effective and safe than intravenous diazepam as first-line treatment for convulsive status epilepticus? A systematic review with metaanalysis of randomized controlled trials

Levetiracetam versus phenytoin for second-line treatment of paediatric convulsive status epilepticus (EcLiPSE): a multicentre, open-label, randomised trial

Levetiracetam versus phenytoin for secondline treatment of convulsive status epilepticus in children (ConSEPT): an openlabel, multicentre, randomised controlled trial

Efficacy of levetiracetam, fosphenytoin, and valproate for established status epilepticus by age group (ESETT): a doubleblind, responsive-adaptive, randomised controlled trial

Clinical efficacy and safety of injectable levetiracetam versus phenytoin as second-line therapy in the management of generalized convulsive status epilepticus in children: An open-label randomized controlled trial

Comparison of phenytoin, valproate and levetiracetam in pediatric convulsive status epilepticus: A randomized doubleblind controlled clinical trial

Randomized controlled trial of levetiracetam versus fosphenytoin for convulsive status epilepticus in children

Clinical effectiveness of levetiracetam compared to fosphenytoin in the treatment of benzodiazepine refractory convulsive status epilepticus

SALT Investigators; Pragmatic Critical Care Research Group. Balanced crystalloids versus saline in the intensive care unit: the SALT randomized trial

SMART Investigators and the Pragmatic Critical Care Research Group. Balanced crystalloids versus saline in critically ill adults

The Plasma Lyte 148 v Saline (PLUS) study protocol: a multicentre, randomised controlled trial of the effect of intensive care fluid therapy on mortality

Anxiety and agitation in mechanically ventilated patients

Cognitive functioning, mental health, and quality of life in ICU survivors: an overview

Reasons for dissatisfaction: a survey of relatives of intensive care patients who died

The delirium experience: what is the effect on patients, relatives and staff and what can be done to modify this?

Grant Acknowledgement: This work was supported by a CIHR Doctoral Research Award to Stephana Cherak (#394654)

Reliability of Inspiratory Holds During Pressure Support Ventilation by References

Driving Pressure Is Associated with Outcome during Assisted Ventilation in Acute Respiratory Distress Syndrome

A Method to Assess the Pressure Developed by Inspiratory Muscles in Patients with Acute Lung Injury Undergoing Pressure Support

Incidence, outcomes and outcome prediction of unplanned extubation in critically ill children: An 11year experience

National Association of Children's Hospitals and Related Institution PICU Focus Group Investigators

Approach to unplanned extubations in a pediatric intensive care unit

Unplanned extubation in a paediatric intensive care unit: prospective cohort study

Impact of a quality improvement intervention on the incidence of unplanned extubations in a Pediatric Intensive Care Unit

Risk factors of unplanned extubation in pediatric intensive care unit

Use and Outcomes of Nasotracheal Intubation Among Patients Requiring Mechanical Ventilation Across U.S. PICUs*. Pediatr Crit Care Med

Unplanned Extubations in Intensive Care Unit: evidences for risk factors. A literature review

Unplanned extubation in critically ill adults: clinical review

Effect of donor, component, and recipient characteristics on hemoglobin increments following red blood cell transfusion

Two-unit red cell transfusions in stable anemic patients

The eICU collaborative research database, a freely available multi-center database for critical care research

Association Between Immigrant Status and End-of-Life Care in Ontario

Maslach burnout inventory

Nursing practice

An Official Critical Care Societies Collaborative Statement

Consequences of Moral Distress in the Intensive Care Unit: A Qualitative Study

Nurse-physician perspectives on the care of dying patients in intensive care units: Collaboration, moral distress, and ethical climate*

Causes of moral distress in the intensive care unit: A qualitative study

Moral distress and burnout among cardiovascular surgery intensive care unit healthcare professionals: a prospective cross-sectional survey

Burnout in the intensive care unit: it's a team problem

Using thematic analysis in psychology

Grant acknowledgement: This work was supported by the QEII Foundation's Translating Research into Care Healthcare Improvement Research Funding Program (Grant #: 893267, funding year

Frailty in elderly people

Biomarkers of frailty in older persons

The impact of frailty on intensive care unit outcomes: a systematic review and meta-analysis

From Coronary Care Units to Cardiac Intensive Care Units: Recommendations for Organizational, Staffing, and Educational Transformation

A global clinical measure of fitness and frailty in elderly people

Acquiring knowledge in intensive care: merits and pitfalls of randomized controlled trials by

Negative trials in critical care: why most research is probably

A stepwise approach to justify phase III randomized clinical trials and enhance the likelihood of a positive result by Daniel F. McAuley

Understanding and misunderstanding randomized controlled trials by T Angus Deaton

Delta inflation: a bias in the design of randomized controlled trials in critical care medicine by Scott K Aberegg

Physiology versus evidence-based guidance for critical care practice Luciano Gattinoni, Eleonora Carlesso and Alessandro Santini Critical Care

Do trials that report a neutral or negative treatment effect improve the care of critically ill patients? No. Jean-Louis Vincent

We should abandon randomized controlled trials in the intensive care unit. Jean-Louis Vincent

Negative trials in critical care medicine and the hurdles by Matthieu Legrand

Sydney Green et al: Outcomes and Statistical Power in Adult Critical Care Randomized Trials

Figure 1 -Do Negative Trials Tend to Be Larger in Size?

Agitation After Subarachnoid Hemorrhage: A Frequent Omen of Hospital Complications Associated with Worse Outcomes

Rest-Activity Cycle Disturbances in the Acute Phase of Moderate to Severe Traumatic Brain Injury

Actigraphy to Evaluate Sleep in the Intensive Care Unit. A Systematic Review

Actigraphy to Measure Physical Activity in the Intensive Care Unit: A Systematic Review

Grant Acknowledgement: Williamson, D is supported by a Fonds de recherche du Québec -Santé (FRQ-S) clinical scientist career grant. Saavedra-Mitjans, M is supported by a Fundación Alfonso Martín Escudero research scholarships in universities or centres abroad

cultural backgrounds may experience less satisfaction with quality of care at the EOL. More research is needed to validate and understand the quality and experience of EOL care that is provided to patients and families from diverse ethnocultural backgrounds.Conclusion: EOLC is a significant source of burnout and moral distress for our ICU team. Although it is highly regarded as an integral part of ICU care, the volume of exposure to death and dying, discordance within the healthcare team or between the team and patient's decision makers regarding level of treatment and a lack of support services were predominate sources of burden. Suggestions to build resilience focused on developing a culture of awareness, support and communication.

We found that among patients admitted to a dedicated CICU in a large quaternary care hospital, frailty was associated with increased adverse clinical outcomes, including increased cardiovascular and all-cause mortality. The assessment of clinical frailty may provide important prognostic information to clinicians and patients, which may further aid in goals-of-care decision making. Further research is needed to evaluate the impact of potential interventions on outcomes in patients with frailty admitted to CICUs.

Alghamdi, Naif 1, 2 ; Major, Paityn 1 ; Chaudhuri, Dipayan 1 ; Tsui, Janice 3 ; Brown, Brent 4 ; Rochwerg, Bram

Wollny, Krista 1, 2, 3 ; Williams, Cameron B. 4 ; Al-Abdwani, Raghad 5 ; Dunn, Carol 6 ; Maccartney, Jason 6 ; Frndova, Helen 6 ; Chin, Norbert 6 ; Stephens, Derek 7 ; Parshuram, Christopher

Swinton, Marilyn 1 ; Boyle, Anne 2, 3 ; Brandt-Vegas, Daniel 4, 5 ; Cheung, Jason 4, 5 ; Clarke, France 6, 7 ; Cook, Deborah 4, 5, 6, 7 ; Dennis, Brittany 4 ; Dionne, Joanna 4 ; Neala Hoad 6 ; Fiest, Kristen 8 ; Frances, Raza 4 ; Hanmiah, Rajandar 4, 5 ; Heels-Ansdell, Diane 7 ; Huynh, Jessica 4, 5 ; Khalid, Zara 4, 5 ; Reid, Julie 9 ; Rudkowski, Jill 4, 5, 6 ; Soth, Mark 4, 5, 6 ; Takaoka, Alyson 6 ; Toledo, Felida 10 

In an embedded mixed-methods study, we enrolled decedents who had >95% probability of death or a decision to withdraw life support. We recorded patient, wish and clinician characteristics. We interviewed clinicians caring for >1 patient 2-10 weeks postmortem. Interview transcripts were analyzed using a qualitative descriptive approach. Results: From March 16-July 1, 2020, 45 patients were enrolled in the 3WP in the ICU (n=34); COVID ward (n=7) or medical step-down unit (n=4). We interviewed 45 clinicians (16 nurses, 10 physicians, 8 residents, 9 others) with 13.7 (11.5) [mean (SD)] years of clinical experience. Interviews were conducted by videoconference (n=25) or phone (n=20). A third (28.9%) of patients had an antemortem virtual visit with a relative or friend. Though few (4.2%) terminal wishes were for a real-time technology-mediated connection, this was more common than in pre-pandemic times (0.5%, p<0.001). Our main finding in the qualitative data related to increased use of technologymediated connection at the EOL. Themes included: a) What, when and how technology-mediated communication was used: Clinicians described mainly using phone communication with families, and using baby monitors to communicate with other clinicians and patients in isolation rooms. The video platforms facilitated patientfamily connections, and was used on the COVID ward for virtual staff huddles. b) Gains realized with technology-mediated communication: Clinicians reported more frequent family phone calls to provide updates, offer support and review goals of care (GOC). Videoconferencing was described as the 'next best thing' to an in-person family visit, allowing images of their loved one including pets, their room, and sometimes their clinicians. The introduction of video technology was identified as a positive feature of Introduction: Negative trials are common in critical care literature. One review from 2008 found that 62 (83%) of 75 RCTs investigating mortality were negative .The most recent review was published in 2014 which includes all published RCTs in 16 high impact journal from 2007-2013 and showed that 63% (92 of 146 ) RCTs in critical care were negative, and 90% were negative when mortality was the primary outcome A negative RCT is not necessarily true & indicative of lack of treatment effect but it can also be a false negative as a result of many methodologic reasons or insensitive outcome selection. It certainly requires further exploration on why this is happening and how to increase the chances of success of RCT. The impact of negative trials is rarely discussed, this may include premature abandonment of promising interventions, adding noise to the total body of evidence, increasing chance of research waste, enhancing feeling of negativism, and exposing a large number of patients to interventions with a very low yield, which may create an ethical dilemma. The views surrounding the value of conducting underpowered RCTs are variable, some feel that negative RCTs are detrimental and is a waste of resources, and others feel they are important to inform systematic reviews and that individual trials are seldom definitive. Objectives: To better understand the proportion of negative RCTs over the past decade, and explore potential variables that could render the results of RCTs to be negative, we aim to conduct a meta-epidemiologic study looking at all published RCTs in the critical care field since 2013. Methods: A librarian conducted the search Two reviewers searched The Cochrane Library, MEDLINE, and EMBASE databases from June 2013 up to December 2019. Results: 911 articles included for our systematic review. 96 articles were published in 2019 & will be presented in CCF fellow day. A higher proportion of trials were positive 61% & 39% negative. Some of the characteristics of these trials are: negative trials have almost an equal proportion of single vs multi center: 54% vs 46% respectively. While the majority positive RCT trials are single centre (80%). regarding geographic locations, Negative trials were conducted in the following areas: 14% International (includes 4 or more countries), 30% in Asia, 30% Europe, 22% USA & 3% Brazil. For positive trials the majority were done in Asia 63% vs 20% Europe, 2% Canada & Brazil, 7% USA & 5% in Africa. The primary outcomes selected in negative trials were :14% multiple/composite, 32% physiological parameter, 32% patient important outcomes, 22% mortality outcome alone. While positive trials: 27% multiple/composite ,45%physiological parameter, 26% patient important outcome ,2% mortality outcome alone. Regarding size of the trials see the figures. Equal proportion of negative & positive trial were terminated early 8% up to 13% of negative trials has a Spin vs 25% of positive trials. 21% of negative trials has no reporting of power calculation vs 50% of positive trials. Conclusions: The proportion of positive trials in adult critical care has increased in 2019. Positive trials tend to be of lower quality than Negative trials. The increase may reflects our comprehensive search which was not restricted to high impact journals as the previous reviews or due to a trend of less use of mortality as the sole primary outcome. Introduction: In response to the call to increase capacity to care for critically ill COVID-19 patients, our hospital increased its number of critical care (CC) beds. This entailed assessing the organizational capability to staff critical care during critical points when staffing supply is inadequate to meet clinical demands. Upskilling healthcare professionals (HCPs) was identified as a strategy. We developed and implemented an upskilling education program for redeployed HCPs who are not currently working in CC but have useful skills to support CC teams. The upskilled HCPs are supervised by those with relevant CC training and experience. Objectives: To describe the development and implementation of the upskilling education program of HCPs, who are not currently working in critical care, to support the care of critically ill COVID-19 patients. Method: 1) Identification of education program developers and facilitators; 2) interdepartmental collaboration of professional practice, education, critical care, medical surgical and redeployment departments, 3) identification of HCPs by unit managers to participate in the upskilling program, and 4) implementation of the upskilling program inclusive of a) eight-hour in-class session, b) completion of on-line and simulation courses, and c) completion of three buddy shifts in CC. Results: Eighty five HCPs participated in the program, and 79% (n=67/85) responded to the post-survey evaluation. Majority (n=65/85) did not have CC experience. Using Likert Scale (1=very poor, 2=poor, 3=good, 4=excellent), respondents rated the content and presentation excellent (range 3.49-3.73). Themes that emerged from qualitative feedback included "concise and comprehensive information on care of COVID-19 patients"; "covered nursing role and responsibilities in POD model during pandemic"', and "facilitators provided safe learning space and knowledgeable, experience-based responses to questions to allay anxiety of redeployed HCPs". All 85 HCPs have completed all the elements of the upskilling education program. Conclusion: The upskilling program showcased commitments of HCPs to patient care. The authors quickly put together the education program in under a week. As a result, we developed a pool of HCPs who are trained to support the care of critically ill patients during pandemic. It highlighted interprofessional and interdepartmental collaboration in pandemic preparedness. The program underlined the importance of professional judgement and the need to assess own level of competencies and accountabilities when redeployed to unfamiliar working environment to perform other roles or duties while ensuring patients receive safe care during pandemic. Introduction / Background: Agitation is a common behavior in intensive care patients following acute traumatic brain injury (TBI). Agitation can prolong recovery of TBI patients due to delayed mechanical ventilation weaning or mobilization.(1) TBI patients can also suffer from sleep-wake disturbances which impede the recovery of posttraumatic amnesia.(2) Actigraphy, which measures rest-wake rhythms using movements with an accelerometer, has been used as an alternative to polysomnography to estimate sleep and to measure physical activity in outpatients' settings. In the ICU setting, actigraphy has been used for the same purposes, but more studies are needed as it has only been studied in patients in whom analgosedation has been discontinued. (3, 4) Our hypothesis is that actigraphy could be a tool to objectively monitor agitation and to estimate sleep-rest cycles in TBI patients.

The aim of the present study is to describe actigraphy data from critically ill TBI patients receiving analgosedation. Specifically, we compared the mean 24-hour activity between agitated and non-agitated TBI patients and reported consolidation of the rest-activity cycle during ICU stay. confirming the potential of actigraphy to objectively monitor agitation. Sleep-wake consolidation measures were not associated with agitation, suggesting the need to control for other variables.